N/A N=203 Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
Tobacco Dependence
Primary: Mirror-tracing Persistence (in Seconds) — 61.08; 100.34 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=377 Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C
Chronic Hepatitis C
Primary: Sustained Virologic Response (SVR)Rate — 130; 72 participants — p=< 0.001
N/A N=111 Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
Type 2 Diabetes · African American · Cholesterol
Primary: ApoB Levels in African American Men With Diabetes and Those Without. — 80; 65 mg/dL — p==0.002
Phase 2 N=51 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Fallopian Tube Carcinoma · Primary Peritoneal Carcinoma · Recurrent Ovarian Carcinoma
Primary: Tumor Response — 23.4 Percentage of participants
Phase 2 N=39 Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Advanced Malignant Mesothelioma · Recurrent Malignant Mesothelioma
Primary: Objective Response (Partial and Complete) Per RECIST — 1 participants
Phase 2 N=368 One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
Asthma
Primary: Morning Peak Expiratory Flow (mPEF) — 346.42; 362.54; 352.87; 329.75 L/min
Phase 3 N=836 Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Major Depressive Disorder
Primary: Physical Examination Findings — 758; 76; 484; 40 participants
Phase 3 N=600 Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
Major Depressive Disorder
Primary: Change From Baseline in the 24-item Hamilton Depression Scale Total Score at Week 6 — -13.87; -14.61 scores on a scale — p=0.407
Phase 1 N=20 Ketogenic Diet for Recurrent Glioblastoma
Recurrent Glioblastoma
Primary: Applicability as Measured by Discontinuation of Study Treatment Due to Intolerability — 15 percent of participants
Phase 3 N=256 A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
Primary: Overall Survival (OS) — 17.54; 15.51 months — p=0.822
Phase 3 N=135 An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
Myelodysplastic Syndrome
Primary: Overall Response Rate (ORR): Number of Participants Who Achieved Either Complete Remission (CR), Partial Remission (PR), or Marrow Complete Remission (mCR)…
Phase 4 N=70 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL)
Cataract
Primary: Mean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm — 0.07; 0.61 logMAR visual acuity
Phase 2 N=51 Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy
Cervical Priming
Primary: Change in Diameter of the Internal Cervical os From Baseline (Pre-treatment) to Just Prior to the Hysteroscopy Procedure (Post-treatment). — 2.2; 2.3; 1.5 mm
Early Phase 1 N=28 Pentoxifylline Treatment of Acute Pancreatitis
Acute Pancreatitis
Primary: Change in C-Reactive Protein (CRP) — 48.4; 60.6; 62; 154 mg/L — p=0.62
Phase 4 N=16 Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
Diabetes
Primary: Objective: Comparisons of the Effects of Co-administration of Sitagliptin and Metformin Alone or in Combination Versus Placebo on Baseline Endogenous Glucose Production…